UBS maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $160 to $185.
UBS Maintains Neutral on DexCom, Raises Price Target to $185
UBS maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $160 to $185.
Benzinga · 11/07/2019 12:36